Ligand Pharmaceuticals (LGNDZ) Times Interest Earned (2016 - 2025)
Ligand Pharmaceuticals (LGNDZ) has disclosed Times Interest Earned for 16 consecutive years, with $7.76 as the latest value for Q4 2025.
- Quarterly Times Interest Earned rose 171.06% to $7.76 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $8.7 through Dec 2025, up 216.67% year-over-year, with the annual reading at $8.7 for FY2025, 216.83% up from the prior year.
- Times Interest Earned hit $7.76 in Q4 2025 for Ligand Pharmaceuticals, down from $60.36 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of $3078.0 in Q3 2023 to a low of -$83.75 in Q4 2022.
- Historically, Times Interest Earned has averaged $156.79 across 5 years, with a median of $5.78 in 2024.
- Biggest five-year swings in Times Interest Earned: plummeted 1092.11% in 2022 and later surged 8180.5% in 2023.
- Year by year, Times Interest Earned stood at $8.44 in 2021, then tumbled by 1092.11% to -$83.75 in 2022, then skyrocketed by 69.39% to -$25.63 in 2023, then skyrocketed by 57.42% to -$10.91 in 2024, then surged by 171.06% to $7.76 in 2025.
- Business Quant data shows Times Interest Earned for LGNDZ at $7.76 in Q4 2025, $60.36 in Q3 2025, and $7.32 in Q2 2025.